- Previous Close
5.48 - Open
5.93 - Bid 5.40 x --
- Ask 5.41 x --
- Day's Range
5.40 - 5.50 - 52 Week Range
3.91 - 7.33 - Volume
8,610,100 - Avg. Volume
13,337,206 - Market Cap (intraday)
8.741B - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.23 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 24, 2023
- 1y Target Est
--
Zhejiang Hisoar Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers antibiotics, cardiovascular products, hypoglycemic products, fine chemicals, dyes, intermediates, and other products, as well as clindamycin products. It also provides pharmaceutical, dyestuff, and other related services. The company was founded in 1966 and is based in Taizhou, China.
www.hisoar.com2,612
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 002099.SZ
View MorePerformance Overview: 002099.SZ
Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002099.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002099.SZ
View MoreValuation Measures
Market Cap
8.74B
Enterprise Value
8.38B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.97
Price/Book (mrq)
1.60
Enterprise Value/Revenue
4.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-19.05%
Return on Assets (ttm)
-1.57%
Return on Equity (ttm)
-6.50%
Revenue (ttm)
1.94B
Net Income Avi to Common (ttm)
-369.49M
Diluted EPS (ttm)
-0.23
Balance Sheet and Cash Flow
Total Cash (mrq)
1.48B
Total Debt/Equity (mrq)
20.45%
Levered Free Cash Flow (ttm)
347.11M